Skip to menu Skip to content Skip to footer

2025

Journal Article

Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation

Nakagaki, Midori, Hajkowicz, Krispin, Roberts, Jason A and Henden, Andrea S (2025). Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation. Expert Review of Anti-infective Therapy, ahead-of-print (ahead-of-print), 1-14. doi: 10.1080/14787210.2025.2527970

Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation

2025

Journal Article

p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice

Nelles, Ricky, Tallack, Michael R., Tate, Courtney, Hunt, Stewart, Aung, Hnin, Henden, Andrea, Jones, Lee and Seymour, Louise (2025). p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice. Pathology, 57 (4), 489-494. doi: 10.1016/j.pathol.2024.11.011

p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice

2025

Journal Article

Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies

Lindsay, Daniel, Henden, Andrea, Nelles, Ricky, Elliott, Thomas M. and Collins, Louisa G. (2025). Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies. Applied Health Economics and Health Policy, 23 (3) 659595, 507-517. doi: 10.1007/s40258-024-00927-8

Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies

2025

Journal Article

Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease

Henden, Andrea S, Lineburg, Katie E, Panikkar, Archana, Mahajan, Arushi, Nelles, Ricky, Wright, Emma, Crooks, Pauline, Raju, Jyothy, Le Texier, Laetitia, Swaminathan, Srividhya, Beagley, Leone, Best, Shannon, Solomon, Matthew, Reddiex, Hilary, Kennedy, Glen, Tey, Siok‐Keen, Neller, Michelle A, Khanna, Rajiv and Smith, Corey (2025). Allogeneic ‘off‐the‐shelf’ SARS‐CoV‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease. Clinical & Translational Immunology, 14 (6) e70038, e70038. doi: 10.1002/cti2.70038

Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease

2024

Journal Article

Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy

Sheehy, Joshua, Scott, Ashleigh P., Henden, Andrea S., Kennedy, Glen, Redmond, Andrew M. and Stewart, Adam G. (2024). Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy. Journal of Antimicrobial Chemotherapy, 79 (8), 2040-2047. doi: 10.1093/jac/dkae209

Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy

2024

Journal Article

Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells

Ekwe, Adaeze Precious, Au, Raymond, Zhang, Ping, McEnroe, Benjamin, Tan, Mei Ling, Saldan, Alda, Henden, Andrea S., Hutchins, Cheryl, Henderson, Ashleigh, Mudie, Kari, Kerr, Keri, Fuery, Madonna, Kennedy, Glen A., Hill, Geoffrey R. and Tey, Siok-Keen (2024). Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells. Cytotherapy, 26 (7), 719-728. doi: 10.1016/j.jcyt.2024.02.023

Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells

2024

Journal Article

Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy

Perera, Nilu, Baidya, Shoma, Weber, Nicholas, Mudie, Kari, Butler, Jason, Curley, Cameron, Henden, Andrea, Hunt, Stewart, Subramoniapillai, Elango, Tey, Siok‐Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy. Transfusion, 64 (4), 762-765. doi: 10.1111/trf.17793

Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy

2024

Journal Article

IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation

Zhang, Ping, Fleming, Peter, Andoniou, Christopher E., Waltner, Olivia G., Bhise, Shruti S., Martins, Jose Paulo, McEnroe, Benjamin A., Voigt, Valentina, Daly, Sheridan, Kuns, Rachel D., Ekwe, Adaeze P., Henden, Andrea S., Saldan, Alda, Olver, Stuart, Varelias, Antiopi, Smith, Corey, Schmidt, Christine R., Ensbey, Kathleen S., Legg, Samuel R.W., Sekiguchi, Tomoko, Minnie, Simone A., Gradwell, Mark, Wagenaar, Irma, Clouston, Andrew D., Koyama, Motoko, Furlan, Scott N., Kennedy, Glen A., Ward, E Sally, Degli-Esposti, Mariapia A. ... Tey, Siok-Keen (2024). IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation. Journal of Clinical Investigation, 134 (7) e174184, 1-15. doi: 10.1172/jci174184

IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation

2023

Journal Article

ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease

Hamad, Nada, Bilmon, Ian, Chee, Lynette, Henden, Andrea, Johnston, Anna, Purtill, Duncan, Bajel, Ashish, Tey, Siok‐Keen, Yeung, David, Cole, Theresa, Lewis, Clinton and Butler, Jason (2023). ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease. Internal Medicine Journal, 53 (12), 2319-2329. doi: 10.1111/imj.16255

ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease

2023

Journal Article

Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia

Wong, Philip, Whiteman, David C., Olsen, Catherine M., Yuan, Yin, Butler, Jason, Curley, Cameron, Durrant, Simon, Henden, Andrea, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2023). Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia. Bone Marrow Transplantation, 59 (1) s41409-023-02138-6, 144-146. doi: 10.1038/s41409-023-02138-6

Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia

2023

Journal Article

Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

Peri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine, 23 (8), 4563-4573. doi: 10.1007/s10238-023-01206-x

Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

2023

Journal Article

Fibre intake and supplementation during treatment for haematological malignancies: a scoping review

Andersen, Sarah, Henden, Andrea, Staudacher, Heidi, Kennedy, Glen and Gavin, Nicole (2023). Fibre intake and supplementation during treatment for haematological malignancies: a scoping review. Journal of Human Nutrition and Dietetics, 36 (5), 1982-1991. doi: 10.1111/jhn.13209

Fibre intake and supplementation during treatment for haematological malignancies: a scoping review

2023

Journal Article

PET assessment of acute gastrointestinal graft versus host disease

Scott, Ashleigh P., Henden, Andrea, Kennedy, Glen A. and Tey, Siok-Keen (2023). PET assessment of acute gastrointestinal graft versus host disease. Bone Marrow Transplantation, 58 (9), 973-979. doi: 10.1038/s41409-023-02038-9

PET assessment of acute gastrointestinal graft versus host disease

2022

Journal Article

High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation

Yuan, Yin, Wong, Philip, Butler, Jason P., Henden, Andrea, Curley, Cameron, Durrant, Simon, Mediwake, Heshani, Morton, A. James, Stewart, Caroline, Subramoniapillai, Elango, Weber, Nicholas, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2022). High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation. Bone Marrow Transplantation, 57 (11), 1-4. doi: 10.1038/s41409-022-01773-9

High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation

2021

Journal Article

CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant

Yeh, Albert C., Varelias, Antiopi, Reddy, Anupama, Barone, Sierra M., Olver, Stuart D., Chilson, Kate, Onstad, Lynn E., Ensbey, Kathleen S., Henden, Andrea S, Samson, Luke, Jaeger, Carla A, Bi, Timothy, Dahlman, Kimberly B., Kim, Tae Kon, Zhang, Ping, Degli-Esposti, Mariapia A., Newell, Evan W., Jagasia, Madan H., Irish, Jonathan M., Lee, Stephanie J. and Hill, Geoffrey R. (2021). CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant. Blood, 138 (26), 2874-2885. doi: 10.1182/blood.2020009492

CMV exposure drives long-term CD57+ CD4 memory T-cell inflation following allogeneic stem cell transplant

2021

Journal Article

IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

Henden, Andrea S., Koyama, Motoko, Robb, Renee J., Forero, Adriana, Kuns, Rachel D., Chang, Karshing, Ensbey, Kathleen S., Varelias, Antiopi, Kazakoff, Stephen H., Waddell, Nicole, Clouston, Andrew D., Giri, Rabina, Begun, Jakob, Blazar, Bruce R., Degli-Esposti, Mariapia A., Kotenko, Sergei V., Lane, Steven W., Bowerman, Kate L., Savan, Ram, Hugenholtz, Philip, Gartlan, Kate H. and Hill, Geoffrey R. (2021). IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease. Blood, 138 (8), 722-737. doi: 10.1182/blood.2020006375

IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

2021

Journal Article

A phase 3 double-blind study of the addition of tocilizumab versus placebo to cyclosporin/methotrexate GvHD prophylaxis

Kennedy, Glen, Tey, Siok-Keen, Buizen, Luke, Varelias, Antiopi, Gartlan, Kate H., Curley, Cameron, Olver, Stuart, Chang, Karshing, Butler, Jason, Misra, Ashish, Subramoniapillai, Elango, Morton, Anthony, Durrant, Simon, Henden, Andrea S, Moore, John, Ritchie, David S, Gottlieb, David, Cooney, Julian P, Paul, Sanjoy K and Hill, Geoffrey R. (2021). A phase 3 double-blind study of the addition of tocilizumab versus placebo to cyclosporin/methotrexate GvHD prophylaxis. Blood, 137 (14), 1970-1979. doi: 10.1182/blood.2020009050

A phase 3 double-blind study of the addition of tocilizumab versus placebo to cyclosporin/methotrexate GvHD prophylaxis

2021

Journal Article

Infectious complications of CAR T-cell therapy: a clinical update

Stewart, Adam G. and Henden, Andrea S. (2021). Infectious complications of CAR T-cell therapy: a clinical update. Therapeutic Advances in Infectious Disease, 8 204993612110367, 1-11. doi: 10.1177/20499361211036773

Infectious complications of CAR T-cell therapy: a clinical update

2020

Journal Article

Mapping functional susceptibilities in AML

Lane, Steven and Henden, Andrea (2020). Mapping functional susceptibilities in AML. The Hematologist, 17 (1). doi: 10.1182/hem.v17.1.10162

Mapping functional susceptibilities in AML

2019

Journal Article

MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota

Koyama, Motoko, Mukhopadhyay, Pamela, Schuster, Iona S., Henden, Andrea S., Hülsdünker, Jan, Varelias, Antiopi, Vetizou, Marie, Kuns, Rachel D., Robb, Renee J., Zhang, Ping, Blazar, Bruce B., Thomas, Ranjeny, Begun, Jakob, Waddell, Nicola, Trinchieri, Giorgio, Zeiser, Robert, Clouston, Andrew D., Degli-Esposti, Mariapia A. and Hill, Geoffrey R. (2019). MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota. Immunity, 51 (5), 885-898. doi: 10.1016/j.immuni.2019.08.011

MHC class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota